No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
SILK Silk Road Medical
- 22.270
- +0.230+1.04%
Close May 22 16:00 ET
878.41MMarket Cap-16255P/E (TTM)
22.720High22.065Low563.94KVolume22.160Open22.040Pre Close12.58MTurnover1.46%Turnover RatioLossP/E (Static)39.44MShares34.13052wk High5.96P/B857.79MFloat Cap6.08052wk Low--Dividend TTM38.52MShs Float75.800Historical High--Div YieldTTM2.97%Amplitude6.080Historical Low22.302Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Silk Road Medical | 10-Q: Quarterly report
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript
Evaluating Silk Road Medical: Insights From 6 Financial Analysts
Ratings for Silk Road Medical (NASDAQ:SILK) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Comments
Insider's recent share sale at current price is viewed negatively. Absence of insider purchases and history of sales over the past year raises caution for potential investors. Despite insider ownership, alignment with other shareholders is weak.
Rising insider sales at Silk Road Medical and no insider purchases in past year suggest potential dip in stock performance. Also, low insider ownership suggests less motivation for long-term company growth.
This should jump to 9+ no problem
$AMN Healthcare Services(AMN.US$ $CBL International(BANL.US$ $Chanson International(CHSN.US$ $Cryoport(CYRX.US$ $MetLife(MET.US$ $MillerKnoll(MLKN.US$ $Nova Lifestyle(NVFY.US$ $InspireMD(NSPR.US$ $Paramount Global-B(PARA.US$ $Ryder System(R.US$ $Recursion Pharmaceuticals(RXRX.US$ $Silk Road Medical(SILK.US$ $60 Degrees Pharmaceuticals(SXTP.US$ $Uber Technologies(UBER.US$ $Victory Capital(VCTR.US$
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg